Sequana Medical NV, has announced that it has received Premarket Approval (PMA) from the US Food and Drug Administration (FDA) to market alfapump for the treatment of recurrent or refractory ascites due to liver cirrhosis in the United States.
Evaluate, a provider of market insights for the pharmaceutical industry, has released its 2025 Preview report featuring updated forecasts for the biopharma market for 2025.
Owen Mumford has announced that its exclusive agreement with Osaka-based NIPRO CORPORATION (NIPRO) to distribute drug delivery device UniSafe has achieved rapid early growth in combination product sales in Japan.
To help potential customers streamline the critical toxicology process, Broughton, a toxicology specialist and regulatory consultancy, has summarised how ToxHQ, Broughton’s data-driven toxicology platform, supports product development.
Greiner Packaging UK & Ireland asks: "How do you know the CO2e impact of your plastic packaging?", and goes on to question how you can properly know what percentage of post-consumer waste a pack contains.
Cartherics Pty has announced that it has been awarded a $300K G-Rex grant to support clinical manufacturing of its lead product CTH-401 for upcoming clinical trials.
SpliceBio has announced that the U.S. Food & Drug Administration (FDA) has cleared its investigational new drug (IND) application for lead program SB-007.
Michael Burkhard and Amr Eltablawi, Hexagon Asset Lifecycle Intelligence, delve into the top trends shaping pharmaceutical and life sciences operations in 2025.
Owkin has launched its latest report, State of the Nation: Opportunities and Challenges for Digital Pathology and AI Solutions, exploring the evolving landscape of digital pathology and AI in healthcare in the UK.
